From BSE to MDT, scientific opinion and public policy on risks in medical devices.

Risk management is not always straightforward, especially if it has to be based on inadequate data. When the arguments are fuelled by fears for public health, politicians are forced to take difficult decisions and all too frequently it is the scientists who come into the firing line over the provision of advice. This is the first of two articles that addresses some specific issues that relate to risks with medical devices in the context of the European Commission.